Medication info
HLB Cimetidine Tablets (Cimetidine)

HLB Cimetidine Tablets (Cimetidine)

Prescription medicationTablet
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
Pale green round tablet
Packaging
1000 tablets/bottle
Approval status
Active

MFDS item code 200503802 · Notified 2005.12.30

Summary

Main use
Treatment of ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome; improvement of gastric mucosal lesions associated with gastritis
Who uses it
Adults · Children
Adult dosage
1. Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. 3. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. 4. Patients with renal insufficiency: Administer 300 mg of this drug twice daily, 12 hours apart. If necessary according to the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more, but use caution. Since the drug may accumulate in the body in patients with severe renal insufficiency, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers serum cimetidine levels. After hemodialysis, administer the drug again according to the schedule. Adjust the dose appropriately according to age and symptoms.
Children's dosage
2. Children: Administer 20 ~ 40 mg/kg per day orally in divided doses.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Treatment of ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome; improvement of gastric mucosal lesions associated with gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
  • erythema
  • edema
  • acute gastritis
View approved original text

This medication is effective for various gastrointestinal diseases such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, ulcers caused by surgery, and Zollinger-Ellison syndrome. It is also used to improve gastric mucosal lesions such as erosions, bleeding, erythema, and edema during acute exacerbations of acute gastritis and chronic gastritis. It helps to protect the gastric mucosa and alleviate inflammation, thereby improving symptoms. Therefore, it is actively used in the treatment of these gastrointestinal diseases and the recovery of mucosal damage.

Dosage and Administration

Adult dosage

1. Adults: Administer cimetidine 400 mg orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, erythema, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. 3. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the dose per administration. Do not exceed 2.4 g per day. 4. Patients with renal insufficiency: Administer 300 mg of this drug twice daily, 12 hours apart. If necessary according to the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more, but use caution. Since the drug may accumulate in the body in patients with severe renal insufficiency, reduce the frequency of administration to a minimum according to the patient's response. Hemodialysis lowers serum cimetidine levels. After hemodialysis, administer the drug again according to the schedule. Adjust the dose appropriately according to age and symptoms.

Children's dosage

2. Children: Administer 20 ~ 40 mg/kg per day orally in divided doses.

Precautions

This medication should be used with caution when administering glass ampoules, as glass fragments may enter the solution upon breaking the container. Special care is required when administering to children or elderly patients. It should not be prescribed to patients who have hypersensitivity to this medication or are taking dofetilide. Patients with impaired kidney or liver function, elderly patients, children under 19 years of age, and patients undergoing dialysis may require dose adjustment or modification of administration intervals, and caution should be exercised in patients with gastric cancer or Helicobacter pylori infection. This medication may affect various organs such as blood, liver, and kidneys, so if any unusual symptoms appear, administration should be stopped immediately and medical advice should be sought. If hypersensitivity reactions such as skin rash, shock, or breathing difficulties occur, use should be stopped immediately. This medication may also cause endocrine disorders such as gynecomastia, increased milk secretion, and erectile dysfunction, so if symptoms occur, consultation with a doctor is necessary. Gastrointestinal symptoms such as abdominal distension, constipation, and diarrhea may occur, so caution is advised. Neurological symptoms such as headache, dizziness, seizures, and mental confusion may occur, so if any signs appear, inform medical personnel immediately. Arrhythmias or severe skin rashes may occur, necessitating immediate action if these symptoms arise. This medication has significant interactions with other drugs, especially anticoagulants, antidepressants, antiarrhythmics, calcium channel blockers, and antifungal agents; dose adjustment should be discussed with a physician when taken together. Pregnant or breastfeeding women should use this medication only if the therapeutic benefit is determined to outweigh the risks, and breastfeeding should be discontinued while using this medication. The safety of this medication in children has not been sufficiently established, so it should be used with caution. Elderly patients are likely to have decreased kidney function; therefore, the dose should be reduced or the administration interval increased. Overdose may lead to respiratory depression, necessitating immediate appropriate treatment at a hospital. When administered in injection form, rapid intravenous injection should be avoided, and it should be administered slowly to reduce the risk of adverse effects. Store out of reach of children, and avoid changing containers as it may adversely affect quality.

Side effects

  • Leukopenia
  • neutropenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • systemic fatigue
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
Show 51 more
  • fever
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevation of AST
  • elevation of ALT
  • liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevation of BUN
  • elevation of serum creatinine
  • shock
  • anaphylactic reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • excessive lactation
  • increased discharge
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • peripheral paresthesia
  • rigidity
  • drowsiness
  • hypochondriacal symptoms
  • altered consciousness
  • confusion state
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • generalized warmth
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, to ensure safe storage, it should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale green round tablet

Package unit

1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.